Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2026)

Twist Bioscience has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $746000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 65.41% year-over-year to $746000.0; the TTM figure through Mar 2026 stood at $746000.0 (up 65.41% YoY), while the FY2025 annual figure was $747000.0, up 83.54% from the prior year.
• Other Non-Current Liabilities advanced to $746000.0 in Q1 2026, from $741000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for TWST reached as high as $8.1 million in Q1 2022 and fell as low as $60000.0 in Q3 2022.
• The 5-year median for Other Non-Current Liabilities is $475000.0 (2023), against an average of $976352.9.
• The widest YoY moves for Other Non-Current Liabilities: up 1830.57% in 2022, down 99.79% in 2022.
• A 5-year view of Other Non-Current Liabilities shows it stood at $60000.0 in 2022, then jumped by 691.67% to $475000.0 in 2023, then retreated by 14.32% to $407000.0 in 2024, then surged by 82.06% to $741000.0 in 2025, then grew by 0.67% to $746000.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $746000.0, $741000.0, and $747000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.